Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ocular Changes After Selective Alpha-2 Receptor Agonist
NCT05670015Unknown
- Sponsor
- Benha University
- Start
- Jan 2023
- Primary completion
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of brimonidine transdermal lotion in Glaucoma (2 arms), sponsored by Benha University. Primary endpoint: Intraocular pressure at 6 months. Status: unknown.
02
Drugs
brimonidine transdermal lotion
03
Conditions
Glaucoma
Beyond the preview
Go deeper on NCT05670015.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05670015.